GlassScriptPhysician profile
Rachel Stein
NPI 1063076834
$3,188.19
in general payments reported to CMS, 2019-2025
7 companies · $1,833 in 2025
The $1,833 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $255 · 2023: $220 · 2024: $881 · 2025: $1,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018 · Travel and Lodging: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,018.04 |
| Travel and Lodging | $915.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,341.65 | 2025 | Glidewire |
| Medtronic, INC. | $660.95 | 2023-2024 | Concertotm, Abre, Solitaire X |
| Stryker Corporation | $454.25 | 2023-2025 | Spinejack, Augment Injectable |
| Boston Scientific Corporation | $284.61 | 2025 | Accolade Sr |
| W. L. Gore & Associates, INC. | $254.77 | 2022 | |
| Imperative Care, INC | $116.20 | 2024 | Symphony Catheter |
| Sirtex Medical INC | $75.76 | 2024 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.